Expert Pearls
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Carnitine Carnitine (L-) I.V. at 20 mg/kg/d over 2-3 minutes after end of every hemodialysis treatment session. [Indian J Med Sci, 200; 60(4):143-53. 44507 (10/2006)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Carnitine - 2 Carnitine (L-) 3 gm/d in hemodialysis patients. [Cardiovas Drugs Ther, 1999;13: 537-546. 35944 (1999)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Folic acid Folic acid 5 mg/d and vitamin B6 250 mg/d. [Eur J Clin Investig, 1995;25:176-181. 34426/22112 (1996)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Folic acid - 2 Folic acid 2.5 mg/d, pyridoxine 25 mg/d and vitamin B12 250 mcg/d regressed plaque in hypertensives and hyperhomocysteinemics. [The Lancet, January 4, 1998;351:263-264. 29156 (1998)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Folic acid - 3 Folic acid 400 µg/d and vitamin B12 400 mcg/d (18 percent, homocysteine fell from 8.12 µmol/l to 6.59 µmol/l). [Am J Clin Nutr, 1998;68:1104-10. 31018 (1999)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Folic acid - 4 Folic acid .4 - 2 mg/d, vitamin B6 10 - 25 mg/d and vitamin B12 100 - 500 ug/d. [NEJ M, February 2, 1995;332(5):328-329. 21740 (1996)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - folic acid, methylcobalamin - 47962 Folic acid 15 mg orally per day and intravenous methylcobalamin 500 mcg in hemodialysis patients. [Am J Kidney Dis, 2010 Apr 27; [Epub ahead of print]. 47962 (09/2011)] Summary Interview PubMed |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - folic acid, vitamin b6, vitamin b12 - 48248 B Vitamins folic acid 0.8 mg/d, vitamin B12 0.5 mg/d and vitamin B6 20 mg/d. [PLoS One, 2010;5(9):e12244. 48248 (11/2010)] Summary Interview PubMed |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Homocysteine levels Homocysteine levels > 10 µmol/l - associated with cardiovascular disease, complications in pregnancy and cognitive function. [Am J Clin Nutr, 1998;68:1104-10. 31018 (1999)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Hyperhomocysteinemia Hyperhomocysteinemia treated with folic acid 1 mg/d, vitamin B-6 10 mg/d and vitamin B12 12 ug/d; an additional 30% non-fasting homocysteine reduction occurs in non-fasting hemodialysis patients with the addition of folic acid 15 mg/d, vitamin B-6 100 mg/d and vitamin B12 1 mg/day. [Kidney International, 1996;49:147-152. 24342 (1996)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Hyperhomocysteinemia - 2 Hyperhomocysteinemia has been associated with placental abruption and infarction, and recurrent pregnancy loss. [Placenta 1999;20:519-529. 32996 (1999)] Summary Interview |
| Risk factor for myocardial infarction, stroke, intermittent claudication and preclinical carotid artery atherosclerosis. [NEJ M, February 2, 1995;332 (5):328-329. 21740 (1996)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - N-acetylcysteine N-acetylcysteine was given IV(50 mg/kg) or possibly 1800-2000 mg/d P.O.. [Pharmacological Research, May,1999;110:727-738. 35594/35497 (2001)] Summary Interview |
|
Homocysteinemia/Homocystinuria/Hyperhomocysteinemia - Obstetric/gynecologic disorders Obstetric/gynecologic disorders associated with elevated homocysteine - cervical dysplasia; eclampsia/preclampsia; fetal growth retardation; neural tube defects; ovarian cancers; recurrent spontaneous abortions. [Hum Repro Update 1999;5(4):64-72. 32725 (1999)] Summary Interview |
| Powered by Sigsiu.NET |  |
